Morgan Stanley Maintains Equal-Weight on Exelixis, Raises Price Target to $60
Benzinga Newsdesk 23 hours ago
Analyst RatingsNewsPrice Target
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $53 to $60.
Morgan Stanley analyst Sean Laaman maintains Exelixis (NASDAQ:EXEL) with a Equal-Weight and raises the price target from $53 to $60.